Stock Events

Stock Events

Alnylam Pharmaceuticals (A1LN34.SA) Q3 2015 Earnings

6AugConfirmed

Q4 2014

Q1 2015

Q2 2015

Q3 2015

-3

-2.26

-1.53

-0.79

Details

Expected EPS

-2.612126

Actual EPS

-3.000415

Surprise EPS

-0.39

Surprise Percent

+14.86%

Description

Alnylam Pharmaceuticals (A1LN34.SA) has reported earnings of -3.000415 per share for Q3 2015.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.